ASTH Astrana Health, Inc.
Healthcare$38.54+1.82%ClosedMarket Cap: $1.91B
As of 2026-05-26
Valuation
P/E (TTM)
61.63
PEG
—
P/B
2.31
P/S
0.53
EV/EBITDA
16.55
DCF Value
$53.15
FCF Yield
8.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.3%
Operating Margin
2.5%
Net Margin
0.9%
ROE
3.9%
ROA
1.3%
ROIC
3.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $965.1M | 9.4% | $28.5M | $14.4M | $— | — |
| Q4 null | $950.5M | 8.3% | $18.4M | $6.0M | $— | — |
| FY null | $3.18B | 9.3% | $78.5M | $22.5M | $— | — |
| Q3 null | $956.0M | 8.5% | $19.2M | $373.0K | $— | — |
| Q2 null | $654.8M | 11.9% | $20.3M | $9.4M | $— | — |
| Q1 null | $620.4M | 11.5% | $20.6M | $6.7M | $— | — |
| Q4 null | $665.2M | 9.5% | $720.0K | $-7.0M | $— | — |
| FY null | $2.03B | 13.3% | $89.3M | $43.1M | $— | — |
| Q3 null | $478.7M | 15.4% | $28.4M | $16.1M | $— | — |
| Q2 null | $486.3M | 13.6% | $30.1M | $19.2M | $— | — |
| Q1 null | $404.4M | 17.0% | $30.1M | $14.8M | $— | — |
| Q4 2023 | $353.0M | 11.0% | $-3.9M | $12.4M | $0.26 | — |